HRV PHARMA
Wockhardt seeks 14-year data shield for India-made drugsMumbai-based Wockhardt has struck success in its innovative research on a range of antibiotic drugs, bridging a global pipeline gap for dif...
HRV Pharma buys Germany's PhateboThe acquisition marks virtual pharmaceutical company HRV's entry beyond active pharmaceutical ingredients (APIs) into finished formulations...
Virtual pharma API firm HRV preparing for IPO, DRHP likely in H1 of 2027: SourcesHRV Pharma CEO Hari Kiran Chereddi says investing in capacity at partner facilities, exploring acquisitions for market access; forecasts Rs...
Trump slaps 100% tariff on branded drugs; Indian pharma companies see limited near-term impactPlayers like Sun Pharma, Dr. Reddy’s and Cipla, who derive 30-50% of their revenues from the US market, brace for potential disruption to t...
Load More